COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 363: Articles 3621-3630  | Next

Long COVID in a highly vaccinated population infected during a SARS-CoV-2 Omicron wave - Australia, 2022
Woldegiorgis, M., Cadby, G., Ngeh, S., Korda, R., Armstrong, P., Maticevic, J., Knight, P., Jardine, A., Bloomfield, L., Effler, P.
10.1101/2023.08.06.23293706 — Posted: 2023-08-09
National Changes in Diabetes Care Practices during the COVID-19 Pandemic: Prospective Study of US Adults
Vashist, K., Hassan, S., Weber, M. B., Quarells, R. C., Patel, S. A.
10.1101/2023.08.06.23293722 — Posted: 2023-08-09
What Risk Factors to Cause Long COVID and Its Impact on Patient Survival Outcomes when Combined with the Effect from Organ Transplantation in the Acute COVID
Dong, J., Nyandemoh, A. N., Anzalone, J., Dai, H., Mannon, R.
10.1101/2023.08.03.23293622 — Posted: 2023-08-08
Prediction of Daily New COVID-19 Cases - Difficulties and Possible Solutions
Liu, X.
10.1101/2023.08.04.23293429 — Posted: 2023-08-08
Four Models of Wastewater-Based Surveillance for SARS-CoV-2 in Jail Settings: How Monitoring Wastewater Complements Individual Screening
Kennedy, S. S., Spaulding, A. C., SWANSS Writing Group
10.1101/2023.08.04.23293152 — Posted: 2023-08-08
Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model
Mundo Ortiz, A. I., Nasri, B.
10.1101/2023.08.04.23293662 — Posted: 2023-08-08
Genetic Variant rs1205 is Associated with COVID-19 Outcomes: The Strong Heart Study and Strong Heart Family Study.
Best, L. G., Erdei, E., Haack, K., Kent, J. W., Malloy, K., Newman, D. E., O'Leary, M., O'Leary, R., Sun, Q., Navas-Acien, A., Franceschini, N., Cole, S. A.
10.1101/2023.08.04.23293551 — Posted: 2023-08-08
Infant and Neonatal Mortality During the Covid-19 Pandemic: An Interrupted Time Series Analysis From Five Low- and Middle-Income Countries
Wagner, Z., Heft-Neal, S., Wang, Z., Jing, R., Bendavid, E.
10.1101/2023.08.03.23293619 — Posted: 2023-08-08
NVX-CoV2373 ancestral and NVX-CoV2540 BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters
Bricker, T. L., Joshi, A., Soudani, N., Scheaffer, S., Patel, N., Xabier, M. G., Smith, G., Diamond, M., Boon, A. C.
10.1101/2023.08.07.552330 — Posted: 2023-08-08
Within-host evolution of SARS-CoV-2: how often are mutations transmitted?
Korosec, C. S., Wahl, L. M., Heffernan, J. M.
10.1101/2023.08.08.552503 — Posted: 2023-08-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).